Feedback
The current prices are delayed. Login to see live prices.
Ambuja Cements Ltd.
(AMBUJACEM)
501234567893012345678980123456789.3012345678950123456789
-4.45 (-0.82%)
Updated 15:59 28/03 IST
Add
Today's low
₹536.30
Today's high
₹552
52 week low
₹453.05
52 week high
₹706.95
Open
₹544.9
Prev Close
₹542.8
Volume (shares)
1,557,007
Total Trading Value
84.51 Cr
Technicals
SMA
Value
Signal
12-SMA
482.35
Bullish
20-SMA
492.7
Bullish
50-SMA
517.64
Bullish
100-SMA
539.55
Bullish
200-SMA
591.31
Bearish
Discussions
• Mar 27 6:49 PM
#AMBUJACEM Stock price reached at resistance zone of 539.20 now if today close above that level then next level will open fo
9
2
4
• Jan 28 12:30 AM
• Mar 26 12:56 AM
2
• Mar 22 11:46 PM
• Feb 1 6:59 PM
Positional Buy Ambujacem between 490-485 SL-474.9 TGT-419-429-449 CMP-490...read more
20
16
7
• Feb 12 1:55 AM
Buy Ambuja Cement 500 PE @ ₹9.25 to ₹10
Stop Loss: ₹8.50...read more
12
2
10
• Feb 5 2:58 PM
AMBUJACEM HIT FIRST TGT 519 BOUGHT @ 490-485 Positional Buy Ambujacem between 490-485 SL-474.9 TGT-519-529-549 CMP-490...read more
4
• Mar 4 1:43 AM
• Feb 1 6:56 PM
Positional Buy Ambujacem between 490-485 SL-474.9 TGT-419-429-449 CMP-490read more
1
1
1
• Feb 4 11:44 PM
• Feb 6 2:38 PM
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of Ambuja Cements Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of Ambuja Cements Ltd. is Rs 542.8 as of 28 March 2025.
What is the Market Capitalization of Ambuja Cements Ltd. ?
The current market cap of Ambuja Cements Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of Ambuja Cements Ltd.?
Ambuja Cements Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.
What is the 52-week high/low of Ambuja Cements Ltd.?
The 52-week high of Ambuja Cements Ltd. is Rs 706.95 and the 52-week low is Rs 453.05
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2025